Authors of new Cochrane Review remain uncertain about effect of widely used medicine on ADHD symptoms, despite large amount of research. Some evidence of increased sleeplessness and loss of appetite ...

LONDON (Reuters) - Researchers voiced concern on Wednesday about poor quality studies on the popular ADHD treatment Ritalin, saying evidence of some benefits, but also of sleep problems and appetite ...

Findings from a new Cochrane Review caution clinicians to weigh the benefits and risks more carefully when prescribing methylphenidate. A team of Cochrane researchers conducted a comprehensive ...

According to a survey conducted in 2020, more than 366 million adults worldwide have ADHD. Apart from prescription drugs such as Medikinet, commonly known as Ritalin, there are few treatment options ...

Children who are underweight are more likely to stop taking their ADHD medication within a year. These are the findings of a study conducted at the University of Gothenburg on methylphenidate, a ...

A team of health experts warned via a new Cochrane Review that physicians should take caution in prescribing the drug methylphenidate, commonly known for its brand name Ritalin, to patients with ...

Long-term treatment of ADHD may be linked to cardiovascular disease, but many people stop taking these medications in the first year. People who take medication for attention deficit hyperactivity ...